What is cystic fibrosis

Understanding Cystic Fibrosis

Cystic fibrosis is a serious genetic disorder affecting the cells that produce mucus, sweat, and digestive juices in the body. In CF patients, these secretions become abnormally thick and sticky instead of thin and slippery. This thick mucus accumulates in the lungs and pancreas, causing severe respiratory and digestive problems. CF is one of the most common life-threatening genetic disorders among Caucasians in North America, though it affects people of all ethnic backgrounds.

Genetic Inheritance

Cystic fibrosis is an autosomal recessive disorder caused by mutations in the CFTR (Cystic Fibrosis Transmembrane Conductance Regulator) gene. For someone to have CF, they must inherit a mutated gene copy from both parents. If a person inherits one mutated copy and one normal copy, they become a carrier but do not have the disease and typically have no symptoms. When both parents are carriers, there is a 25% chance with each pregnancy that their child will have CF, a 50% chance the child will be a carrier, and a 25% chance the child will have neither the condition nor be a carrier.

Effects on the Respiratory System

In the lungs, thick mucus clogs the airways and creates an environment where bacteria thrive, leading to chronic and recurrent lung infections. These infections cause inflammation, damage airways, and gradually reduce lung function. Patients experience persistent coughing, shortness of breath, wheezing, and fatigue. Over time, CF can lead to severe complications including bronchiectasis (permanent damage to airways), pneumothorax (collapsed lung), and respiratory failure, which is the leading cause of death in CF patients.

Digestive and Nutritional Effects

The thick mucus in the pancreas blocks the release of digestive enzymes needed to break down fats, proteins, and carbohydrates. This causes malabsorption, leading to vitamin deficiencies, poor weight gain and growth, and diabetes development in some patients. Roughly 85% of CF patients have pancreatic insufficiency and require daily pancreatic enzyme supplements to aid digestion and nutrient absorption. Additionally, CF-related diabetes affects about 30% of adults with CF.

Treatment and Prognosis

While there is no cure, treatments have dramatically improved CF outcomes. Treatment regimens include daily airway clearance techniques (like chest physiotherapy), inhaled medications to thin mucus and prevent infections, oral antibiotics, and pancreatic enzymes. Newer therapies including modulator drugs that target the CFTR protein malfunction have shown significant benefits. With advances in treatment and care, median life expectancy has increased substantially; people born with CF today have a significantly better prognosis than previous generations. Regular monitoring, pulmonary function testing, and multidisciplinary care are essential for managing the disease.